Table 1 Demographic and lifestyle characteristics and baseline cognitive performance within the three intervention groups
Variable | CT (n = 16) | PT (n = 18) | WLC (n = 20) | Statistic | p |
|---|---|---|---|---|---|
Age: M (SD) | 70.2 (5.8) | 73.7 (6.2) | 70.3 (5.5) | F (2,51) = 2.11 | 0.13 |
Gender: male / female | 8 / 8 | 6 / 12 | 10 / 10 | χ 2(2) = 1.35 | 0.51 |
Education in years: M (SD) | 13.3 (4.0) | 14.2 (3.0) | 15.2 (3.7) | F(2,51) = 1.18 | 0.32 |
MMSE: M (SD) | 27.8 (2.6) | 27.8 (1.7) | 28.2 (2.2) | F(2,51) = 0.14 | 0.87 |
WST z-score: M (SD) | 0.64 (0.57) | 0.69 (0.96) | 1.01 (0.92) | F(2,51) = 1.07 | 0.35 |
Global cognition: M (SD) | 0.08 (0.64) | 0.04 (0.62) | -0.10 (0.82) | F(2,51) = 0.33 | 0.72 |
Memory: M (SD) | -0.02 (0.83) | 0.16 (0.67) | -0.11 (0.98) | F(2,51) = 0.48 | 0.62 |
Attention / executive functions: M (SD) | 0.19 (0.64) | -0.08 (0.75) | -0.08 (0.78) | F(2,51) = 0.75 | 0.48 |
Number of reported activities: M (SD) | 8.4 (3.4) | 8.7 (2.5) | 9.3 (2.5) | F(2,49) = 0.39 | 0.68 |
Variety of activitiesa: M (SD) | 0.27 (0.13) | 0.28 (0.09) | 0.30 (0.09) | F(2,49) = 0.60 | 0.55 |
Antidementive medication: no / yes | 11 / 5 | 17 / 1 | 18 / 2 | χ 2(4) = 5.80 | 0.21 |
Antidepressants: no / yes | 15 / 1 | 18 / 0 | 19 / 1 | χ 2(2) = 1.08 | 0.58 |